CSL Seqirus: A Pillar of Pandemic Preparedness with Fifth BARDA Award for Avian Influenza

CSL Seqirus: A Pillar of Pandemic Preparedness with Fifth BARDA Award for Avian Influenza CSL Seqirus, a leading global biotechnology company, has once again demonstrated its commitment to pandemic preparedness by securing its fifth award from the Biomedical Advanced Research and Development Authority (BARDA). This latest contract, valued at $121.4 million, is aimed at bolstering […]

Bavarian Nordic Secures $157M Contract to Replenish US Supplies of Smallpox/Mpox Vaccine Jynneos

Bavarian Nordic Secures $157M Contract to Replenish US Supplies of Smallpox/Mpox Vaccine Jynneos Bavarian Nordic, a Danish biotechnology company, has recently secured a substantial contract worth $156.8 million from the United States government to replenish the nation’s stockpile of the smallpox and mpox vaccine, Jynneos. This deal marks a significant milestone for Bavarian Nordic as […]